-
1321
Making a Comeback: Syphilitic Hepatitis in a Patient with Late Latent Syphilis—Case Report and Review of the Literature
Published 2022-10-01“…Virologic study revealed negative results for antibodies against common viral hepatitis and metabolic and autoimmune disease. …”
Get full text
Article -
1322
Development of an Ex Vivo Assay for Identification of Infectious Hepatitis E Virus in Different Kinds of Food Samples
Published 2023-10-01“…Hepatitis E virus (HEV) is a positive-sense single-stranded RNA virus and a major cause of acute viral hepatitis. HEV is responsible for 20 million infections worldwide in humans every year. …”
Get full text
Article -
1323
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Published 2024-02-01“…HCC risk factors include non-viral hepatitis, alcohol abuse, environmental exposures, and genetic factors. …”
Get full text
Article -
1324
The immunogenicity of GSK’s recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience
Published 2017-08-01“…Introduction: The World Health Organization recommends hepatitis B virus (HBV) vaccines to be included in national immunization schedules everywhere, and has adopted the strategic goal of halting viral hepatitis as a major public health threat by 2030, under which vaccination plays a major role. …”
Get full text
Article -
1325
Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients with Moderate-Severe Psoriasis and Concomitant Diseases
Published 2022-05-01“…Our aim was to perform an in-depth literature review and discuss the potential risks associated with biologic therapy in patients with psoriasis and concurrent diseases with a focus on the influence of novel therapeutic agents on liver function in the context of hepatopathies, particularly viral hepatitis. A multidisciplinary teamwork and periodic evaluation of psoriasis patients under biologic therapy is highly encouraged to obtain an accurate management for each case.…”
Get full text
Article -
1326
Infections in the era of immunobiologicals
Published 2024-04-01“…This article will discuss the main risks of infection associated with the use of immunobiologicals, addressing the risk in immunocompetent and immunosuppressed patients, vaccination, fungal infections, tuberculosis, leprosy, and viral hepatitis, and how to manage the patient in the most diverse scenarios.…”
Get full text
Article -
1327
Streamlined and on-demand preparation of mRNA products on a universal integrated platform
Published 2023-07-01“…The proposed integrated platform shows advantages for the universal and on-demand preparation of mRNA products, offering the potential to facilitate broad access to mRNA technology and enable the development of mRNA products, including the rapid supply of new mRNA-based vaccines in pandemic situations and personalized mRNA-based therapies for oncology and chronic infectious diseases, such as viral hepatitis and acquired immune deficiency syndrome.…”
Get full text
Article -
1328
SHARED: An International Collaboration to Unravel Hepatitis C Resistance
Published 2021-08-01Get full text
Article -
1329
Syphilis in pregnant women in the municipality of Catanduvas-SC
Published 2019-10-01“…It was also observed that 91.8% of the pregnant women performed laboratory tests and three rapid tests for the diagnosis of Syphilis, Viral Hepatitis, and HIV, being a test in each gestational trimester. …”
Get full text
Article -
1330
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
Published 2018-02-01“…In Europe, alcohol abuse accounts for approximately half of all liver cancer cases and it will become the leading cause of hepatocellular carcinoma in the next future with the sharp decline of chronic viral hepatitis. The pathophysiology of alcohol-induced carcinogenesis involves acetaldehyde catabolism, oxidative stress and chronic liver inflammation. …”
Get full text
Article -
1331
Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
Published 2021-08-01“…The present review summarizes the advances in the research of HBV DNA integration, focusing on the evolutionary and molecular side of the integration events along with the arising clinical aspects in the light of WHO’s commitment to eliminate HBV and viral hepatitis by 2030.…”
Get full text
Article -
1332
The Role of Infection and Autoimmunity in Urticaria and Angioedema as a Common Entity
Published 2021-08-01“…The author looked at evidence, using a keyword search, for the role of viral and bacterial infections in acute, acute recurrent, and chronic urticaria and angioedema, including COVID-19, herpes, viral hepatitis, and Helicobacter pylori.…”
Get full text
Article -
1333
Perioperative management of patients with drug addiction
Published 2023-06-01“…Common comorbidities in this population include human immunodeficiency virus, viral hepatitis, and infections caused by resistant strains of microorganisms. …”
Get full text
Article -
1334
-
1335
The risks of perinatal HIV/HCV co-infection and the evolution of treatment tactics of the disease in children (clinical case)
Published 2022-07-01“…The effectiveness of modern tactics for the treatment of HIV infection and chronic viral hepatitis C has been demonstrated.…”
Get full text
Article -
1336
A Role for the Biological Clock in Liver Cancer
Published 2019-11-01“…HCC onset and progression is related to B and C viral hepatitis, alcoholic and especially non-alcoholic fatty liver disease (NAFLD)-related milieu of fibrosis, cirrhosis, and chronic inflammation. …”
Get full text
Article -
1337
Fructose and the Liver
Published 2021-06-01“…Non-alcoholic fatty liver disease (NAFLD) is a term widely used to describe excessive fatty infiltration in the liver in the absence of alcohol, autoimmune disorders, or viral hepatitis; it is attributed to obesity, high sugar and fat consumption, and sedentarism. …”
Get full text
Article -
1338
Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure
Published 2020-12-01“…ACLF frequently occurs in close temporal relationship to a precipitating event, such as acute alcoholic, drug-induced or viral hepatitis or bacterial infection and, in cases without precipitating events, probably related to intestinal translocation of bacterial products. …”
Get full text
Article -
1339
Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine
Published 2017-12-01“…Hepatitis B virus (HBV) is the primary cause of chronic viral hepatitis worldwide. Currently, there are 5 oral nucleos(t)ide analogs (NAs) approved for chronic hepatitis B (CHB) treatment and include lamivudine, adefovir, telbivudine (LtD), entecavir (ETV), and tenofovir disoproxil fumarate (TDF). …”
Get full text
Article -
1340
Hepatitis C Screening in Intravenous Drug Users Under Treatment with Methadone: An Action Reserch Study
Published 2011-04-01“…Background: Intravenous drug users (IVDUs) are the most at risk group for viral hepatitis C and injection drug is responsible to more than 60% of HCV infected new cases worldwide. …”
Get full text
Article